Home Page
The latest articles, features and news.



Read About...

Adolescence
AIDS/HIV Treatments
Andropause
Assisted Reproduction
Circumcision
Dating
Dicks & History
Enlargement
Fertility
Firefly Talks Dicks
Gay and Bi
Gender
Getting It Up
Male Peculiarities
Paternity
Pecker Problems
Penis Size
Prostate Cancer
Relationships
STDs


Search Articles

Custom Search



Discussion Forums


Q and A
Sexuality
Dating
Size
Pics





26 April 2011
Herpes vaccine hamstrung by African strains of virus
by George Atkinson

Harvard Medical School Researchers working on a herpes vaccine say that strains of genital herpes in Africa are far more virulent than those in the United States.

Identification of the properties of the African viruses would open the door to developing a better vaccine, research leader David M. Knipe says. At present, the vaccine farthest along in development (it is headed for clinical trials in about a year) works best against the U.S. strains of herpes simplex 2, but it also protects laboratory animals from the African strains if given in very high doses.

In southern Africa, infection rates among adults for genital herpes are exceedingly high - around 80-90 percent, compared to slightly less than 20 percent in the United States.

According to Knipe, animal tests demonstrate clearly that the strains of herpes virus seen in sub-Saharan Africa are more virulent than the herpes simplex 2 virus strains seen in the United States. That difference suggests that an effective vaccine will probably have to be given to people in Africa in larger or more frequent doses.

Part of the promise of a herpes vaccine is that it can help reduce the impact of HIV/AIDS in southern Africa. Epidemiological studies have shown that genital herpes infection is associated with a three-fold increase in the risk of HIV infection. "If the rate of herpes infection can be reduced, it's conceivable the rate of HIV/AIDS infection will also come down, perhaps reducing the death rate," says Knipe.

Knipe's approach to vaccine development is based on using abnormal, live, mutant viruses to stimulate protective immune responses. These disabled viruses cannot multiply inside cells or cause symptomatic disease, but they do contain enough of the right proteins and molecules needed to arouse detection by a healthy immune system.

Although it has been difficult to create a vaccine for genital herpes, vaccines against a closely related herpes virus - varicella zoster virus, the cause of chicken pox and shingles - proved successful and are now widely used. This gives reason for optimism about a genital herpes vaccine.

Related:
Herpes linked to Alzheimer's disease
Many unaware of their herpes infection
Herpes Drug Reduces HIV Infectiousness

Source: Harvard Medical School




Home Page    Contact Us    Privacy


Your use of this website indicates your agreement to our terms and conditions of use.
Copyright 2000 - 2012 altPenis.com and its licensors. All rights reserved.